Basic information Safety Supplier Related

4,6-DIFLUOROPYRIMIDINE

Basic information Safety Supplier Related

4,6-DIFLUOROPYRIMIDINE Basic information

Product Name:
4,6-DIFLUOROPYRIMIDINE
Synonyms:
  • Pyrimidine, 4,6-difluoro- (6CI,8CI,9CI)
  • 4,6-DIFLUOROPYRIMIDINE
  • PyriMidine,4,6-difluoro-
CAS:
2802-62-2
MF:
C4H2F2N2
MW:
116.07
Product Categories:
  • PYRIMIDINE
  • Pyridines, Pyrimidines, Purines and Pteredines
Mol File:
2802-62-2.mol
More
Less

4,6-DIFLUOROPYRIMIDINE Chemical Properties

Boiling point:
125℃
Density 
1.376
Flash point:
29℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-4.88±0.17(Predicted)
form 
liquid
color 
Clear, yellow
InChI
InChI=1S/C4H2F2N2/c5-3-1-4(6)8-2-7-3/h1-2H
InChIKey
MCLDVUCSDZGNRR-UHFFFAOYSA-N
SMILES
C1=NC(F)=CC(F)=N1
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38-41
Safety Statements 
26-36/37/39-39
HazardClass 
IRRITANT
HS Code 
2933599590
More
Less

4,6-DIFLUOROPYRIMIDINE Usage And Synthesis

Synthesis

1193-21-1

2802-62-2

a) Preparation of 4,6-difluoropyrimidine (STR13): 4,6-dichloropyrimidine (223.5 g, 1.5 mol), potassium fluoride (279.6 g, 4.8 mol) and tetrabutylammonium bromide (6.0 g, 0.0186 mol) were dissolved in cyclobutanesulfone (1 L). The reaction mixture was heated at 180-190 °C for 3.5 h followed by distillation to afford the target product 4,6-difluoropyrimidine as a white liquid (115 g, 66% yield).

References

[1] Patent: US5977363, 1999, A
[2] Patent: US5977363, 1999, A
[3] Patent: EP794177, 1997, A1
[4] Patent: EP794177, 1997, A1
[5] Chemistry Letters, 1993, # 3, p. 509 - 512

4,6-DIFLUOROPYRIMIDINESupplier

Nanjing Asfam Pharmaceutical Technology Co., Ltd. Gold
Tel
025-58867862 18751812725
Email
sales@ace-pharm.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Nanjing Lynsci Chemical Co., Ltd
Tel
+86-025-83208253 +86-13851694729
Email
layefe@163.com
Shanghai Raise Chemical Technology Co.,Ltd
Tel
+86-021-50935922
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com